German-grown medical cannabis is available for purchase and sale by local pharmacies for the first time, the Federal Institute for Drugs and Medical Devices (BfArM) announced late Wednesday.

Pharmacies can use the portal by Cansativa GmbH to purchase medical marijuana from one of three contracted cultivators, two of which are subsidiaries of Canadian producers Aurora Cannabis and Tilray, respectively, and the other being Germany-based Demecan.

The three companies were chosen to cultivate marijuana in Germany in 2019 after a long-delayed application process to provide product for the largest medical cannabis market in Europe.

View the full article at mjbizdaily.com